Evidence map›Paper›PMID 41868969›Full record

ArticleImaging neuroscience (Cambridge, Mass.)

Towards molecular selectivity in pharmacoimaging: Comment on van den Bosch and Cools.

Timothy Lawn, Mitul A Mehta

Abstract read
In one paragraph

Article in Imaging neuroscience (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Timothy LawnAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.ORCID https://orcid.org/0000-0002-1643-5987
Mitul A MehtaDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0003-1152-5323

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular-enriched fMRI promises to bridge the gap between neurotransmitter systems and macro-scale network dynamics, yet empirical support has remained elusive. Commenting on van den Bosch and Cools (2025), we evaluate the first attempt to validate Receptor-Enriched Analysis of functional Connectivity by Targets (REACT) against individual-level PET data. They found that the effects of methylphenidate on dopamine-enriched networks, but not noradrenaline-enriched networks, tracked individual differences in striatal dopamine synthesis capacity and reward prediction error signaling. While establishing the validity of molecular-enriched networks for this specific use case, the study also exposes critical methodological boundary conditions. We discuss the constraints imposed by spatial collinearity between molecular targets, the influence of state-dependent effects in task-based paradigms, and the necessity of pharmacological blocking studies for establishing causal selectivity. Finally, we look to the future of molecular-informed functional imaging.

Indexed as

multimodal imagingneurotransmitterpharmacological fMRIREACTreceptor-enriched analysis of functional connectivity by targetsvalidation

Identifiers

PMID41868969
PMCPMC13000545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.